lobbying_activities: 825828

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
825828	b87cc342-3d23-4a64-a800-19c4019d2b10	Q3	MEHLMAN CONSULTING, INC.	284950	FOREST LABORATORIES INC	2009	third_quarter	GOV	Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2009-10-13T14:01:00-04:00